SCHEMBL21031587

SCHEMBL21031587

CON(CC(=O)OCC(C)C)CC(=O)OCC(C)C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.45
▸ ALDH1A1 P00352 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ PPARG P37231 1/20 0.32
▸ NCOA2 Q15596 1/20 0.32
▸ NCOA1 Q15788 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ NCOA3 Q9Y6Q9 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ RAB9A P51151 1/20 0.30
▸ P2RX4 Q99571 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19594830 0.78 TSHR (0.43) TSHRALDH1A1TDP1L3MBTL1PPARG
SCHEMBL26778457 0.77 TSHR (0.42) TSHRALDH1A1TDP1L3MBTL1PPARG
SCHEMBL16782927 0.77 TSHR (0.42) TSHRALDH1A1TDP1L3MBTL1PPARG
SCHEMBL23065597 0.75 TSHR (0.41) TSHRALDH1A1TDP1L3MBTL1PPARG
SCHEMBL28225850 0.75 TSHR (0.41) TSHRALDH1A1TDP1L3MBTL1PPARG
SCHEMBL19257403 0.73 TSHR (0.39) TSHRALDH1A1TDP1L3MBTL1PPARG
SCHEMBL16782926 0.73 CA1 (0.40) TSHRALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL243431 0.72 TSHR (0.56) TSHRALDH1A1TDP1L3MBTL1PPARG
SCHEMBL334176 0.72 TSHR (0.50) TSHRALDH1A1TDP1L3MBTL1POLB
SCHEMBL29587773 0.72 TSHR (0.38) TSHRALDH1A1TDP1L3MBTL1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10617662-B2 Autophagy activation-induced compound for improving skin inflammation for aging INCOSPHARM CORPORATION (KR) 2020-04-14 — — US disclosed
US-20190160033-A1 NOVEL AUTOPHAGY ACTIVATION-INDUCED COMPOUND FOR IMPROVING SKIN INFLAMMATION FOR AGING INCOSPHARM CORPORATION (KR) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10617662-B2 Autophagy activation-induced compound for improving skin inflammation for aging TFEB, ATG7, BECN1 TSHR 4768/4885ALDH1A1 4347/4885TDP1 2258/4885
US-20190160033-A1 NOVEL AUTOPHAGY ACTIVATION-INDUCED COMPOUND FOR IMPROVING SKIN INFLAMMATION FOR AGING TFEB, ATG7, BECN1 TSHR 4826/4885ALDH1A1 4369/4885TDP1 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback